ACES Pharma is a leading manufacturer and supplier of specialty biochemicals and pharmaceutical fine chemicals. The company focuses on custom synthesis and technology (development) services, including:

  • Custom-synthesis of cytotoxins from grams to hundreds of grams
  • MMAE, MMAF and analogs
  • MMAE-linkers and MMAF-linkers
  • Ansamitocin, Maytansine and derivates
  • Maytansinoid-linkers, such as DM1, DM3 and DM4
  • Calicheamicin and analogs
  • Linkers (cleavable and non-cleavable linkers)
  • Customized new toxins, linkers and ADCs

1 Deer Park Drive, Suite L-3
Monmouth Jct, NJ 08852
USA

Web: ACES Pharma

MabPlex
 
Previous articleAbzena PLC
Next articleADC Bio
ADC Review | Editorial Team
The editorial team of ADC Review | Journal of Antibody-drug Conjugates (ISSN 2327-0152) consists of an Editor-in-Chief, Deputy Editors, and Consulting Editors. Members of the editorial team are chosen based on their demonstrated expertise in one or more areas of oncology or hematology and their active engagement in research, the development, manufacturing and clinical application of antibody-drug conjugates (ADCs).